Clonality and Measurable Residual Disease (MRD) Testing on the Illumina NextSeq Sequencers← ALL PUBLICATIONSClonality and Measurable Residual Disease (MRD) Testing on the Illumina® NextSeqTM SequencersJune 2024AUTHOR Austin Jacobsen Invivoscribe Marketing2024-06-21T12:55:12-07:00